A BiTE, AMG 424, with a lower CD38-binding affinity together with CD3 binding to T cells, was recently developed and its preclinical activity was evaluated using in vitro and in vivo models of human MM [50]. The gene discussed is CD38; the disease is Miyoshi myopathy.